| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and iO Health-FZE, an innovator in AI-driven healthcare technology, today announced a strategic agreement aimed at delivering Optima AI across the Middle East and North Africa (MENA).
Through this agreement, Claritev has secured exclusive rights to license, integrate, and resell iO Health's Optima AI platform in the MENA region. Optima AI is a next-generation, AI-powered solution that helps to streamline financial and administrative processes for healthcare providers, helping them reduce claim denials, optimize workflows, and improve financial outcomes.
By integrating Optima AI into Claritev's existing suite of products and solutions, the two companies will endeavor to jointly enable hospitals, clinics, and payors to improve claims management efficiency, transparency, and decision-making through advanced analytics that aim to enhance both clinical and financial performance.
Posted In: CTEV
